The value of PET/CT to assess clinically negative necks

European Archives of Oto-Rhino-Laryngology

Volumn 269, Issue 11, 2012, Pages 2411-2414

  Ozer, Enver ^a   Naiboǧlu, Bariş ^b   Meacham, Ryan ^c   Ryoo, Cherie ^a   Agrawal, Amit ^a   Schuller, David E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Clinically negative neck; Head and neck carcinoma; Lymph node metastasis; PET CT

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CENTER; CANCER OF UNKNOWN PRIMARY SITE; CANCER PATIENT; CANCER STAGING; CERVICAL LYMPH NODE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MOUTH CANCER; NECK DISSECTION; OROPHARYNX CANCER; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY;

CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; NECK; NECK DISSECTION; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84867261838     PISSN: 09374477     EISSN: 14344726     Source Type: Journal    
DOI: 10.1007/s00405-012-1926-6     Document Type: Review

References (17)

1. Spiro RH, Alfonso AE, Farr HW, Strong EW (1974) Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. Am J Surg 128:562-567
2. Cheng MF, Wu YW, Liu KL, Yen RF, Wu YM, Hsu C, Chang YT, Tzen KY, Wang HP (2011) Diagnostic value of 18F-FDG-PET/CT in indeterminate inWltrative hepatic lesions in an endemic area of viral hepatitis. Nucl Med Commun 32:252-259
3. Rioja J, Rodríguez-Fraile M, Lima-Favaretto R, Rincón-Mayans A, Peñuelas-Sánchez I, Zudaire-Bergera JJ, Parra RO (2010) Role of positron emission tomography in urological oncology. BJU Int 106:1578-1593 (Review)
4. Park HK, Jeon K, Koh WJ, Suh GY, Kim H, Kwon OJ, Chung MP, Lee KS, Shim YM, Han J, Um SW (2010) Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 15:1179-1184
5. Dirisamer A, Halpern BS, Flöry D, Wolf F, Beheshti M, Mayerhoefer ME, Langsteger W (2010) Integrated contrast-enhanced diagnostic whole-body PET/CT as a Wrst-line restaging modality in patients with suspected metastatic recurrence of breast cancer. Eur J Radiol 73:294-299
6. Low G, Tho LM, Leen E, Wiebe E, Kakumanu S, McDonald AC, Poon FW (2008) The role of imaging in the pre-operative staging and post-operative follow-up of rectal cancer. Surgeon 6:222-231 (Review)
7. Branstetter BF 4th, Blodgett TM, Zimmer LA, Snyderman CH, Johnson JT, Raman S, Meltzer CC (2005) Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 235:580-586
8. Fleming AJ Jr., Johansen ME (2008) The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients. Curr Opin Otolaryngol Head Neck Surg 16:127-134 (Review)
9. Yoon DY, Hwang HS, Chang SK, Rho YS, Ahn HY, Kim JH, Lee IJ (2009) CT, MR, US, 18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 19:634-642
10. Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O (2007) The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg 137:130-137
11. Murakami R, Uozumi H, Hirai T, Nishimura R, Shiraishi S, Ota K, Murakami D, Tomiguchi S, Oya N, Katsuragawa S, Yamashita Y (2007) Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 68:377-382
12. Schwartz DL, Ford E, Rajendran J, Yueh B, Coltrera MD, Virgin J, Anzai Y, Haynor D, Lewellyn B, Mattes D, Meyer J, Phillips M, Leblanc M, Kinahan P, Krohn K, Eary J, Laramore GE (2005) FDG-PET/CT imaging for preradiotherapy staging of headand- neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 61:129-136
13. Roh JL, Yeo NK, Kim JS, Lee JH, Cho KJ, Choi SH, Nam SY, Kim SY (2007) Utility of 2-[18F] Xuoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma. Oral Oncol 43:887-893
14. Nahmias C, Carlson ER, Duncan LD et al (2007) Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer. J Oral Maxillofac Surg 65:2524-2535
15. Schöder H, Carlson DL, Kraus DH et al (2006) 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47:755-762
16. Richard C, Prevot N, Timoshenko AP, et al (2010) Preoperative combined 18-Xuorodeoxyglucose positron emission tomography and computed tomography imaging in head and neck cancer: does it really improve initial Nstaging? Acta Otolaryngol 130:1421- 1424
17. Yamazaki Y, Saitoh M, Notani K, Tei K, Totsuka Y, Takinami S, Kanegae K, Inubushi M, Tamaki N, Kitagawa Y (2008) Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med 22:177-184